Showing results (511-520 of 1,797) with videos related to
Sort By:
Pageof 180
Cell Chemical Biology|December 5, 2017
Conserved Lipid and Small-Molecule Modulation of COQ8 Reveals Regulation of the Ancient Kinase-like UbiB FamilyAndrew G Reidenbach, Zachary A Kemmerer, Deniz Aydin, et al.Cell Chemical Biology|December 14, 2019
Degradation of Polycomb Repressive Complex 2 with an EED-Targeted Bivalent Chemical DegraderFrances Potjewyd, Anne-Marie W Turner, Joshua Beri, et al.Cell Chemical Biology|February 27, 2018
SRPKIN-1: A Covalent SRPK1/2 Inhibitor that Potently Converts VEGF from Pro-angiogenic to Anti-angiogenic IsoformJohn M Hatcher, Guowei Wu, Chuyue Zeng, et al.Cell Chemical Biology|June 25, 2016
From SubPAR to PAR, into the CryoEM, and More MacrolidesCell Chemical Biology|June 25, 2016
Prevention of Serpin Misfolding by RNA AptamersXiaohua Zhou, Paul J DeclerckCell Chemical Biology|March 6, 2018
Snapshots of C-S Cleavage in Egt2 Reveals Substrate Specificity and Reaction MechanismSeema Irani, Nathchar Naowarojna, Yang Tang, et al.Cell Chemical Biology|December 19, 2017
Site-Specific Installation of Succinyl Lysine Analog into Histones Reveals the Effect of H2BK34 Succinylation on Nucleosome DynamicsYihang Jing, Zheng Liu, Gaofei Tian, et al.Cell Chemical Biology|January 20, 2023
Pharmacological management of disease by overcoming structural adversityRichard N SifersCell Chemical Biology|July 27, 2021
Chemo-proteomics exploration of HDAC degradability by small molecule degradersYuan Xiong, Katherine A Donovan, Nicholas A Eleuteri, et al.Cell Chemical Biology|July 30, 2021
The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitorsVinayak Palve, Claire E Knezevic, Daniel S Bejan, et al.Pageof 180